Chemotherapy payload of anti-insoluble fibrin antibody-drug conjugate is released specifically upon binding to fibrin
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-32601-0.pdf
Reference32 articles.
1. Matsumura, Y. Cancer stromal targeting (CAST) therapy. Advanced drug delivery reviews 64, 710–719 (2012).
2. Yasunaga, M., Manabe, S. & Matsumura, Y. New concept of cytotoxic immunoconjugate therapy targeting cancer-induced fibrin clots. Cancer science 102, 1396–1402 (2011).
3. Yasunaga, M., Manabe, S., Tarin, D. & Matsumura, Y. Cancer-stroma targeting therapy by cytotoxic immunoconjugate bound to the collagen 4 network in the tumor tissue. Bioconjug Chem 22, 1776–1783 (2011).
4. Matsumura, Y., Kimura, M., Yamamoto, T. & Maeda, H. Involvement of the kinin-generating cascade in enhanced vascular permeability in tumor tissue. Japanese journal of cancer research: Gann 79, 1327–1334 (1988).
5. Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 20, 4368–4380 (2002).
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antibody-drug conjugates for hepato-pancreato-biliary malignancies: “Magic bullets” to the rescue?;Cancer Treatment Reviews;2024-09
2. Augmentation of the EPR effect by mild hyperthermia to improve nanoparticle delivery to the tumor;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07
3. Contemporary Approaches to Immunotherapy of Solid Tumors;Cancers;2024-06-19
4. Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview;Frontiers in Immunology;2024-01-17
5. Targeted Glioma Therapy—Clinical Trials and Future Directions;Pharmaceutics;2024-01-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3